KAUSHIK J DAVE Insider Trading $ATNM Actinium Pharmaceuticals, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for KAUSHIK J DAVE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of KAUSHIK J DAVE. KAUSHIK J DAVE is Executive Vice President in ANTARES PHARMA, INC. ($ATRS) and CEO and Interim CFO in Actinium Pharmaceuticals, Inc. ($CTVN) and President, CEO and Interim CFO in Actinium Pharmaceuticals, Inc. ($CTVN).
KAUSHIK J DAVE in Actinium Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of KAUSHIK J DAVE: President, CEO and Interim CFO
Holdings: 88,500 shares
Latest Transaction: Mar 16 2017
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of KAUSHIK J DAVE in Actinium Pharmaceuticals, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 16 2017 | CTVN | Actinium Pharmaceu ... | DAVE KAUSHIK J | CEO and Interim CFO | Option Exercise | A | 1.39 | 250,000 | 347,500 | 250,000 | |
| Apr 18 2016 | CTVN | Actinium Pharmaceu ... | DAVE KAUSHIK J | CEO and Interim CFO | Option Exercise | A | 1.99 | 400,000 | 796,000 | 400,000 | |
| Apr 18 2016 | CTVN | Actinium Pharmaceu ... | DAVE KAUSHIK J | CEO and Interim CFO | Buy | P | 2.01 | 2,000 | 4,020 | 88,500 | 86.5 K to 88.5 K (+2.31 %) |
| Apr 18 2016 | CTVN | Actinium Pharmaceu ... | DAVE KAUSHIK J | CEO and Interim CFO | Buy | P | 2.02 | 8,000 | 16,160 | 86,500 | 78.5 K to 86.5 K (+10.19 %) |
| May 22 2015 | CTVN | Actinium Pharmaceu ... | DAVE KAUSHIK J | President, CEO and ... | Option Exercise | A | 2.52 | 63,063 | 158,919 | 63,063 | |
| May 22 2015 | CTVN | Actinium Pharmaceu ... | DAVE KAUSHIK J | President, CEO and ... | Option Exercise | A | 2.52 | 82,128 | 206,963 | 82,128 | |
| May 22 2015 | CTVN | Actinium Pharmaceu ... | DAVE KAUSHIK J | President, CEO and ... | Sell | D | 2.45 | 25,000 | 61,250 | 85,583 | 110.6 K to 85.6 K (-22.61 %) |
| May 22 2015 | CTVN | Actinium Pharmaceu ... | DAVE KAUSHIK J | President, CEO and ... | Payment of Exercise | F | 2.45 | 12,500 | 30,625 | 85,583 | 98.1 K to 85.6 K (-12.74 %) |
| May 22 2015 | CTVN | Actinium Pharmaceu ... | DAVE KAUSHIK J | President, CEO and ... | Sell | D | 2.45 | 68,000 | 166,600 | 73,083 | 141.1 K to 73.1 K (-48.20 %) |
| May 22 2015 | CTVN | Actinium Pharmaceu ... | DAVE KAUSHIK J | President, CEO and ... | Payment of Exercise | F | 2.45 | 16,000 | 39,200 | 73,083 | 89.1 K to 73.1 K (-17.96 %) |
| May 22 2015 | CTVN | Actinium Pharmaceu ... | DAVE KAUSHIK J | President, CEO and ... | Sell | D | 2.45 | 27,501 | 67,377 | 57,083 | 84.6 K to 57.1 K (-32.51 %) |
| May 22 2015 | CTVN | Actinium Pharmaceu ... | DAVE KAUSHIK J | President, CEO and ... | Payment of Exercise | F | 2.45 | 7,083 | 17,353 | 57,083 | 64.2 K to 57.1 K (-11.04 %) |
| Mar 16 2015 | CTVN | Actinium Pharmaceu ... | DAVE KAUSHIK J | President, CEO and ... | Option Exercise | A | 3.58 | 150,000 | 537,000 | 150,000 |
Page: 1